Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin

Unknown 300 enrolled Lin Liao

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to explore the differences in efficacy and safety of sitagliptin,vildagliptin and saxagliptin and to find which one is more better in treating type 2 diabetes mellitus.

Timeline

Start: 2012-10
Primary completion: 2016-12
Completion: —

Publications

Zhou XJ, Ding L, Liu JX, Su LQ, Dong JJ, Liao L. Efficacy and short-term side effects of sitagliptin, vildagliptin and saxagliptin in Chinese diabetes: a randomized clinical trial. Endocr Connect. 2019 Apr;8(4):318-325. doi: 10.1530/EC-18-0523.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SAXAGLIPTIN ANHYDROUS	Small molecule	5 mg	Oral
Subject	Sitagliptin	Small molecule	100 mg	Oral
Subject	Vildagliptin	Other / unclassified	50 mg	—

Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin

Summary

Timeline

Publications

Drugs

Indications